These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31158471)

  • 1. Targeted Mono-Therapy for Newly Diagnosed Dilated Cardiomyopathy.
    Rajapreyar I; Samson R; Ennezat PV; Jemtel THL
    J Card Fail; 2019 Aug; 25(8):686-689. PubMed ID: 31158471
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy.
    Elliott P
    Heart; 2000 Jul; 84(1):106-12. PubMed ID: 10862601
    [No Abstract]   [Full Text] [Related]  

  • 4. Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction.
    Driscoll A; Currey J; Tonkin AM
    JAMA Cardiol; 2016 Oct; 1(7):842-843. PubMed ID: 27556747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Should beta-adrenergic blockade be part of drug therapy for heart failure?].
    Leinonen H
    Duodecim; 1995; 111(3):209-13. PubMed ID: 8654281
    [No Abstract]   [Full Text] [Related]  

  • 6. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
    Singh TP; Almond C
    J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of cardiac remodeling after treatment of IgG4 related cholangitis.
    Wei Z; Song J; Feng X; Zhang N; Wang L; Xu B
    Int J Cardiol; 2016 Nov; 222():257-259. PubMed ID: 27497106
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Stepwise Approach to the Management of Heart Failure and its Comorbidities.
    Rogers FJ; Saghir Z
    J Am Osteopath Assoc; 2020 Feb; 120(2):90-99. PubMed ID: 31985768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case of the month. Idiopathic dilated cardiomyopathy.
    Parker T
    JAAPA; 2009 Jul; 22(7):70. PubMed ID: 19697577
    [No Abstract]   [Full Text] [Related]  

  • 11. The natural history of dilated cardiomyopathy: how has it changed?
    Merlo M; Gentile P; Naso P; Sinagra G
    J Cardiovasc Med (Hagerstown); 2017 Jan; 18 Suppl 1():e161-e165. PubMed ID: 27828827
    [No Abstract]   [Full Text] [Related]  

  • 12. Higher medication doses in heart failure?
    McCormack J; McAlister FA; Kolber MR
    Can Fam Physician; 2017 Jan; 63(1):e20. PubMed ID: 28115456
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy of dilated cardiomyopathy].
    Guazzi MD; Alimento M; Mundo E; Viecca M
    Cardiologia; 1985 Oct; 30(10):909-12. PubMed ID: 2878720
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?
    Smith I; Jackson I
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):687-90. PubMed ID: 20805745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.
    Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA
    JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dilated cardiomyopathy post-chemotherapy].
    Sbrana F; Greco P; Rovai D
    Recenti Prog Med; 2009 Mar; 100(3):132-6. PubMed ID: 19475840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doses of renin-angiotensin system inhibitors but not beta-blockers predict outcome after ST-elevation myocardial infarction.
    Liu PY; Chen CL; Yu MC; Ko YL; Hsu SY; Chou HH; Yeh KH; Duan DM; Chen MH; Lin JF
    Acta Clin Belg; 2019 Oct; 74(5):334-341. PubMed ID: 30295167
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and beta-blockers in long-term treatment of dilated cardiomyopathy.
    Regitz-Zagrosek V; Leuchs B; Krülls-Münch J; Fleck E
    Am Heart J; 1995 Apr; 129(4):754-61. PubMed ID: 7900628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilated cardiomyopathy : clinical profile and treatment.
    Khalil A; Chawla K; Chakravarti A
    Indian Pediatr; 2000 Nov; 37(11):1242-6. PubMed ID: 11086307
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of the outcome in patients with infantile dilated cardiomyopathy over three decades - The usefulness of long-term gradually medical supportive care.
    Tsuda E; Yamada O; Kitano M
    J Cardiol; 2019 Aug; 74(2):189-194. PubMed ID: 30876708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.